Get the Stockscreener App
9.37
2.19%
-0.21
After Hours:
9.40
0.03
+0.32%
Anavex Life Sciences Corporation stock is traded at $9.37, with a volume of 713.83K.
It is down -2.19% in the last 24 hours and down -13.08% over the past month.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
See More
Previous Close:
$9.58
Open:
$9.52
24h Volume:
713.83K
Relative Volume:
0.70
Market Cap:
$804.83M
Revenue:
-
Net Income/Loss:
$-48.17M
P/E Ratio:
-16.44
EPS:
-0.57
Net Cash Flow:
$-37.10M
1W Performance:
-0.32%
1M Performance:
-13.08%
6M Performance:
+5.28%
1Y Performance:
+79.85%
1-Day Range:
$9.33
$9.685
1-Week Range:
$8.82
$10.40
52-Week Range:
$5.03
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corporation
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Compare AVXL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
9.37 | 762.31M | 0 | -48.17M | -37.10M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Sep-23-21 | Initiated | BTIG Research | Buy |
| Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
| Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-18-19 | Initiated | Janney | Buy |
| May-16-18 | Resumed | Maxim Group | Buy |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Feb-07-17 | Initiated | Noble Financial | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corporation Stock (AVXL) Latest News
Anavex Life Sciences (NASDAQ:AVXL) Trading Down 4.8%Here's What Happened - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Given Buy Rating at HC Wainwright - MarketBeat
D. Boral Capital Reaffirms "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL) - MarketBeat
Anavex Life Sciences (NASDAQ:AVXL) Stock Price Up 9%Here's What Happened - MarketBeat
Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study - MSN
Breakeven On The Horizon For Anavex Life Sciences Corp. (NASDAQ:AVXL) - 富途牛牛
Will Anavex Life Sciences Corp. bounce back from current supportChart Signals & Safe Entry Point Alerts - Newser
Using portfolio simulators with Anavex Life Sciences Corp. included2025 Big Picture & Technical Entry and Exit Alerts - Newser
Anavex Life Sciences at H.C. Wainwright: Strategic Developments in Alzheimer’s - Investing.com
What MACD signals say about Anavex Life Sciences Corp.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Anavex Life Sciences out with New Drug to Fight Effects of Aging - Baystreet.ca
Anavex Life Sciences Corp. Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer's Disease Trial - MarketScreener
Anavex Life Sciences Reports Groundbreaking 48-Week Cognitive Stability Results for Blarcamesine in Early Alzheimer's Disease Treatment - Quiver Quantitative
Anavex: Oral Blarcamesine shows cognitive resilience near normal aging in Alzheimer's trial - MarketScreener
84.7% Cognitive Protection: Anavex's Oral Drug Matches Normal Aging in Landmark Alzheimer's Trial - Stock Titan
Is Anavex Life Sciences Corp.’s growth already priced inQuarterly Performance Summary & Comprehensive Market Scan Insights - beatles.ru
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2025 Earnings Call Transcript - MSN
Anavex Life Sciences Corp. stock trend forecastJuly 2025 News Drivers & Real-Time Buy Signal Alerts - Newser
Has Anavex Life Sciences Corp. found a price floor2025 Growth vs Value & Daily Momentum Trading Reports - Newser
What is the earnings history of Anavex Life Sciences Corp.Quarterly Trade Review & Weekly Setup with ROI Potential - خودرو بانک
Anavex Life Sciences Corp. $AVXL Shares Purchased by Rafferty Asset Management LLC - MarketBeat
How to track smart money flows in Anavex Life Sciences Corp.M&A Rumor & Risk Managed Investment Entry Signals - Newser
Using data tools to time your Anavex Life Sciences Corp. exitTrade Volume Report & Long-Term Safe Investment Ideas - Newser
How institutional ownership impacts Anavex Life Sciences Corp. stockTrade Entry Report & Accurate Technical Buy Alerts - Newser
Sector ETF performance correlation with Anavex Life Sciences Corp.Portfolio Performance Report & Real-Time Stock Movement Alerts - Newser
Pattern recognition hints at Anavex Life Sciences Corp. upside2025 Price Momentum & Reliable Trade Execution Plans - Newser
Anavex Life Sciences Corp. stock volume spike explainedMarket Activity Report & Consistent Profit Trading Strategies - Newser
Is this a good reentry point in Anavex Life Sciences Corp.2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
Trend analysis for Anavex Life Sciences Corp. this weekPortfolio Update Summary & Reliable Intraday Trade Plans - Newser
Price action breakdown for Anavex Life Sciences Corp.July 2025 Chart Watch & Safe Entry Point Identification - Newser
Using data models to predict Anavex Life Sciences Corp. stock movementEarnings Overview Summary & Expert Approved Momentum Ideas - Newser
What does recent volatility data suggest for Anavex Life Sciences Corp.Portfolio Gains Summary & Expert Curated Trade Setups - Newser
How is Anavex Life Sciences Corp. managing supply chain issuesWeekly Stock Summary & Free Technical Confirmation Trade Alerts - خودرو بانک
Using Bollinger Bands to evaluate Anavex Life Sciences Corp.July 2025 Short Interest & Entry Point Confirmation Alerts - Newser
Multi asset correlation models including Anavex Life Sciences Corp.Day Trade & Community Consensus Trade Alerts - Newser
Chart based analysis of Anavex Life Sciences Corp. trendsGlobal Markets & Risk Managed Investment Signals - Newser
Is Anavex Life Sciences Corp. stock poised for growth2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Price momentum metrics for Anavex Life Sciences Corp. explainedJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Statistical indicators supporting Anavex Life Sciences Corp.’s strength2025 Macro Impact & AI Forecasted Stock Moves - Newser
Published on: 2025-09-03 23:07:21 - Newser
How to use Fibonacci retracement on Anavex Life Sciences Corp.Market Activity Recap & Free Weekly Chart Analysis and Trade Guides - Newser
Sentiment analysis tools applied to Anavex Life Sciences Corp.Bond Market & Weekly Momentum Stock Picks - Newser
Is Anavex Life Sciences Corp. forming a double bottom2025 Performance Recap & Low Volatility Stock Suggestions - خودرو بانک
Anavex Life Sciences Corp. stock outlook for YEAR2025 Earnings Impact & High Conviction Trade Alerts - Newser
What’s the beta of Anavex Life Sciences Corp. stockJuly 2025 Price Swings & Weekly Chart Analysis and Trade Guides - خودرو بانک
Using R and stats models for Anavex Life Sciences Corp. forecasting2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Using AI based signals to follow Anavex Life Sciences Corp.Weekly Investment Report & Free Growth Oriented Trading Recommendations - Newser
Can technical indicators confirm Anavex Life Sciences Corp.’s reversalMarket Sentiment Summary & Risk Controlled Stock Pick Alerts - Newser
Anavex Life Sciences Corporation Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):